Chondroitin Sulfate Proteoglycan Core Proteins in the Interphotoreceptor Matrix: A Comparative Study using Biochemical and Immunohistochemical Analysis

• Published in: Experimental eye research 1999-09, Vol.69 (3), p.311-322
• Main Authors: HOLLYFIELD, JOE G, RAYBORN, MARY E, MIDURA, RONALD J, SHADRACH, KAREN G, ACHARYA, SHREETA
• Format: Article
• Language: English
• Subjects: Adult; Aged; Animals; Biological and medical sciences; bovine; Cattle - metabolism; Chondroitin Sulfates - metabolism; chondroitin-4-sulfate; chondroitin-6-sulfate; chondroitinase ABC; chondroitinase AC II; Extracellular Matrix - metabolism; Eye and associated structures. Visual pathways and centers. Vision; Eye Proteins - metabolism; Female; Fundamental and applied biological sciences. Psychology; human; Humans; Immunoenzyme Techniques; interphotoreceptor matrix; Male; Mammals - metabolism; Mice; Mice, Inbred BALB C - metabolism; Middle Aged; Molecular Sequence Data; mouse; Photoreceptor Cells, Vertebrate - metabolism; Proteoglycans - metabolism; rat; Rats - metabolism; retina; Species Specificity; unsulfated chondroitin; Vertebrates: nervous system and sense organs
• ISSN: 0014-4835; 1096-0007
• DOI: 10.1006/exer.1999.0707

This study characterizes the core proteins of chondroitin sulfate-type glycosaminoglycans located in the interphotoreceptor matrix and establishes the tissue distribution of chondroitin immunoreactivity in human, bovine, mouse and rat retinas. Monoclonal antibodies specific to unsulfated (ΔDiOS), 4-sulfated (ΔDi4S) and 6-sulfated (ΔDi6S) chondroitin were employed. Retinal sections and IPM samples were either (a) digested with chondroitinase ABC to expose antibody specific epitopes, (b) double digested with chondroitinase ABC and chondroitinase AC II to remove specific epitopes, or (c) left undigested to evaluate mimotope labeling. In tissue sections from each species studied, positive immunoreactivity to the ΔDi6S antibody was present in the IPM surrounding both rods and cones. In human and bovine, ΔDi6S labeling of the cone matrix compartments was more intense than labeling of the matrix surrounding rods. Intense ΔDi6S immunoreactivity was present surrounding the foveal cones. In mouse and rat, no differences in labeling intensity of IPM surrounding rod and cone photoreceptors were evident, although labeling of the IPM near the apical surface of the retinal pigment epithelium and around the photoreceptor inner segments was more pronounced than that surrounding the outer segments. All ΔDi6S antibody labeling was eliminated with chondroitinase AC II digestion. No IPM immunoreactivity in tissue sections was observed when the ΔDi0S or ΔDi4S antibodies were used. In Western blots of IPM extracts treated with chondroitinase ABC, prominent ΔDi6S immunoreactive bands were present at approximately 230 kD and 150 kD in each species studied, with the exception of the human, where the 150 kD component is not a chondroitin proteoglycan. Each of the prominent ΔDi6S immunoreactive bands showed minor immunoreactivity to the ΔDi4S antibody. No ΔDi0S immunoreactivity was noted in Western blots of IPM samples from any species. All immunoreactivity was lost following chondroitinase AC II digestion. These observations document similarities in the electrophoretic mobility of IPM proteoglycan core proteins released following chondroitinase ABC digestion in the four species studied, but reveal pronounced differences in the tissue distribution. Bovine and human IPM show greater concentrations of ΔDi6S immunoreactivity surrounding cones than rods, whereas rodent tissues show higher concentrations near the retinal pigment epithelium and around the photoreceptor inner segments than